-
QT Imaging closes $10M public offering of 1.2M shares and pre-funded warrants
Offered 1,200,000 shares at $5.00/share and 800,000 pre-funded warrants at $4.9999; gross proceeds $10M, net ~$9M.
-
QT Imaging Q1 revenue $6.5M (+133% YoY); net loss $3.4M; reaffirms FY2026 guidance ~$39M
Revenue of $6.5M up 133% YoY on 13 scanners shipped (vs. 6 in Q1 2025).
-
QT Imaging beats 2025 revenue guidance at $18.9M; guides FY2026 to $39M
Revenue $18.9M, +288% YoY, above $18M guidance; Q4 rev $8.3M (+877% YoY) on 17 scanners shipped.
-
QT Imaging raises CEO salary to $605K, awards $232K bonus & 519.5K RSUs; CFO gets $40.6K bonus & 2.8K RSUs
CEO Raluca Dinu base salary increased to $605K/year from $550K, effective March 20, 2026.
-
QT Imaging posts investor presentation; no financial figures disclosed
Company posted investor presentation on February 25, 2026 on its website.
-
QT Imaging reports Q4 record revenue $8.3M (+877% YoY); 2025 revenue $18.9M, beats guidance
Q4 revenue $8.3M, up 97% QoQ and 877% YoY; record 17 scanners shipped.
-
QT Imaging FY2024 revenue rises to $4.88M; net loss widens to $8.98M
Revenue surged to $4,878,665 from $40,355 in 2023, driven by new distribution agreement.
-
QT Imaging receives Nasdaq approval to uplist from OTCQB; trading begins Jan 28, 2026
QT Imaging Holdings (OTCQB: QTIH) received approval to uplist to Nasdaq Capital Market under ticker QTI.
-
QT Imaging raises ~$155k in private placement to Chairman at $6.43/share plus warrants
Entered Securities Purchase Agreement with Chairman Dr. Avi Katz for $155,002 gross proceeds.
-
QT Imaging signs exclusive UAE distribution deal; minimum $24M revenue from 43 scanners
Exclusive agreement with Al Naghi Medical for QT Breast Acoustic CT and QTI Cloud Platform in UAE.
-
QT Imaging provides pro forma statements reflecting Oct 2025 private placement ($18.2M gross) and $5M debt repayment
Pro forma net loss for Q3 2025 reduced to $(2.35M) ($(0.17)/share) from as-filed $(4.56M) ($(0.47)/share).
-
QT Imaging provides unaudited pro forma financials reflecting $18.18M private placement and $5M debt repayment
Pro forma net loss $20.0M for nine months ended Sep'25; pro forma EPS ($1.49) on 13.5M weighted avg shares.
-
QT Imaging Q3 revenue $4.2M (+339% YoY); raises 2026 outlook to $39M; applies for Nasdaq relisting
Q3 revenue $4.2M, up 15% sequentially from Q2 2025; shipped 9 scanners.
-
QT Imaging Holdings posts November 2025 investor presentation, content not disclosed
Company published an investor presentation on its website on November 10, 2025.
-
QT Imaging implements 3:1 reverse stock split effective October 24, 2025
Reverse stock split at 3:1 ratio became market effective on October 24, 2025.
-
QT Imaging Holdings effects 3:1 reverse stock split effective October 23, 2025
Reverse stock split at 3:1 ratio effective 4:01 p.m. ET on October 23, 2025.
-
QT Imaging approves 3:1 reverse stock split, applies to relist on Nasdaq
Board fixed reverse split at 3:1, effective 4:01 PM ET Oct 23, 2025; shares reduce from ~35.7M to ~11.9M.
-
QT Imaging files pro forma financials reflecting $18.18M private placement and $5M warrant repurchase
Private placement closed Oct 3, 2025 raised ~$18.18M gross from 6.7M shares at $1.50/share plus warrants.
-
QT Imaging raises ~$18M in PIPE financing to fund growth and repay debt; plans NASDAQ relisting
Gross proceeds ~$18.18M from sale of 12,120,798 shares (or pre-funded warrants) at $1.50/share plus warrants.
-
QT Imaging CFO resigns; separation includes $150K payment and consulting with capped fees
CFO Anastas Budagov resigned effective Aug 29, 2025; receives $150K lump sum in lieu of severance.
-
QT Imaging raises CEO Raluca Dinu's base salary to $550K, target bonus to 75%
Base salary increased from $470,000 to $550,000 effective September 1, 2025.
-
QT Imaging repurchases Yorkville warrants for $5M, appoints new CFO Jay Jennings
Repurchased 15M-share Yorkville warrant for $5M; funded by new $5M Lynrock Lake loan, raising total debt to $15.1M.
-
QT Imaging enters exclusive distribution agreement with Gulf Medical for Saudi Arabia
QT Imaging grants Gulf Medical exclusive rights to market and sell Breast Acoustic CT scanners and QTI Cloud Platform subscriptions in Saudi Arabia.
-
QT Imaging shareholders elect directors, ratify auditor, authorize reverse split
Elected Daniel Dickson and James Greene as Class I directors to serve until 2028.
-
QT Imaging grants CEO Raluca Dinu 25,000 stock options at $1.90
Grant of 25,000 non-qualified stock options to CEO under 2024 Equity Incentive Plan.
-
QT Imaging Q2 revenue surges 113% YoY to $3.7M; pursues Nasdaq uplisting
Q2 2025 revenue $3.7M, up 113% from Q2 2024 and 31% from Q1 2025; gross margin 50%.
-
QT Imaging files pro forma reflecting warrant amendment reclassification of $20.2M liability to equity
Pro forma eliminates $20.2M warrant liability, increases paid-in capital by $19.5M, reduces accumulated deficit by $0.7M.
-
QT Imaging amends Lynrock Lake and Yorkville warrants; adds acquisition protection and registration rights
Amends Lynrock Lake warrant (61M shares, $0.40 strike) to protect holder in Cash/Public Acquisition, automatically cashless exercised.
-
QT Imaging posts May 2025 investor presentation; no specific metrics disclosed
Company furnished investor presentation on its website under Regulation FD on May 21, 2025.
-
QT Imaging Q1 revenue $2.8M, 65% gross margin; net loss $11.1M
Revenue $2.8M (65% gross margin), up from $1.4M YoY; shipped 6 scanners vs 3 in Q1 2024.
-
CEO and CFO receive option grants totaling 358,750 shares at $0.6650
CEO Raluca Dinu granted options for 308,750 shares; split between Officer Grant (75k) and Director Grant (233,750).
-
QT Imaging delisted from Nasdaq, trades on OTCQB; raises $500K in insider PIPE
Delisting proceedings initiated by Nasdaq; stock suspended Jan 28, 2025 and now trades OTCQB (QTIH).
-
QT Imaging FY 2024 rev $4.9M from 12 scanners; forecasts $18M for 2025; stock now on OTCQB after Nasdaq delisting
FY 2024 commercial revenue $4.9M vs <$0.1M in 2023; 12 QT Breast Acoustic CT scanners shipped at 54% gross margin.
-
QTI secures $10.1M Lynrock Lake loan, retires Yorkville note, issues 61M warrants
New $10.1M senior secured term loan from Lynrock Lake at 10% interest, matures March 2027.
-
QT Imaging delisted from Nasdaq; shares move to OTC under QTIH
Nasdaq Hearings Panel denied appeal on Jan 24, 2025; suspension effective Jan 28, 2025.
-
QT Imaging subleases Novato office to Dr. Klock's practice for $5,666-$6,011/month through 2027
Subleases space at 3 Hamilton Landing, Suite 160 to QT Imaging Center (sole prop. of Dr. John C. Klock) for exclusive medical practice use.
-
QT Imaging amends notes with YA II PN and Funicular; lowers conversion price, extends maturity
YA II PN note: conversion price lowered to $0.584/share for $1.5M of $8.34M principal; remainder stays at $4.61395.
-
QT Imaging fails to regain Nasdaq bid price compliance; delisting appeal pending
Nasdaq staff notified QT Imaging on Dec 17, 2024 that it failed to regain bid price compliance by Dec 16, 2024.
-
QT Imaging amends distribution deal with Canon subsidiary; extends term to 2026, sets minimum orders
Term extended from Dec 2025 to Dec 2026; exclusivity conditioned on Canon Medical Systems Corp manufacturing pact by Dec 30, 2024.
-
QT Imaging posts investor presentation; no material financial or operational data disclosed
Company posted investor presentation on December 11, 2024 to its website.
-
QT Imaging Q3 scanner sales $0.9M (65% gross margin); amends convertible note to $8.6M; insider PIPE $2.56M
Generated $0.9M scanner sales revenue with 65% gross margin in Q3 2024.
-
QT Imaging receives Nasdaq delisting notice; plans to appeal by Nov 13, 2024
Nasdaq notified QT Imaging on Nov 6, 2024 of delisting proceedings due to failure to maintain $50M market value of listed securities.
-
QT Imaging amends $10M convertible note: maturity extended to Mar 2026, floor price cut to $0.50
Maturity of $10M convertible note extended from Dec 15, 2025 to Mar 31, 2026.
-
QT Imaging enters Omnibus Amendment with YA II PN to extend note maturity and modify payment terms
Maturity date of $10M convertible note extended from June 4, 2025 to December 15, 2025.
-
QT Imaging triggers accelerated payments under Yorkville note; first payment $1.52M
Floor Price Trigger on Sep 11, 2024: daily VWAP below $0.8768 for five trading days.
-
QT Imaging receives Nasdaq MVPHS deficiency notice; third listing standard now in violation
Market Value of Publicly Held Securities below $15M minimum for 31 consecutive business days.
-
QT Imaging posts investor presentation on breast acoustic CT scanner
Presentation posted August 14, 2024 on company website with product and operational info.
-
QT Imaging Q2 2024 revenue $1.7M, 51% gross margin; partners with OU cancer center
Revenue of $1.7M in Q2 2024, up from $1.4M in Q1 2024 and <$0.1M in Q2 2023.
-
QT Imaging enters exclusive U.S. distribution deal with Canon subsidiary NXC Imaging
NXC appointed exclusive reseller for QT Imaging equipment in U.S. and territories, replacing prior Sales Agent Agreement.
-
QT Imaging receives Nasdaq minimum bid price deficiency notice; faces delisting risk
Nasdaq notified QT Imaging on June 17, 2024 that bid price is below $1.00 for 30 consecutive business days.